Scheurer, J., Reisser, T., Leithäuser, F., Messmann, J., Holzmann, K., Debatin, K.-M., & Strauss, G. (2020). Rapamycin-based graft-versus-host disease prophylaxis increases the immunosuppressivity of myeloid-derived suppressor cells without affecting T cells and anti-tumor cytotoxicity. Clinical and Experimental Immunology, 202(3), 407-422. https://doi.org/10.1111/cei.13496 (Original work published 2020)